交易 Merck KGaA - EUR - MRKd CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
价差 | 0.65 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.024161% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | -0.020283% | ||||||||
隔夜费时间 | 22:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | EUR | ||||||||
保证金 | 20% | ||||||||
上市交易所 | Germany | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Merck KGaA ESG Risk Ratings
High Medium Low Negligible
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Feb 3, 2023 | 185.80 | 3.60 | 1.98% | 182.20 | 186.25 | 181.00 |
Feb 2, 2023 | 183.70 | 4.20 | 2.34% | 179.50 | 184.80 | 179.45 |
Feb 1, 2023 | 181.80 | -7.00 | -3.71% | 188.80 | 188.85 | 181.10 |
Jan 31, 2023 | 190.75 | -2.60 | -1.34% | 193.35 | 193.55 | 189.65 |
Jan 30, 2023 | 193.60 | 4.10 | 2.16% | 189.50 | 194.05 | 188.95 |
Jan 27, 2023 | 190.05 | -1.40 | -0.73% | 191.45 | 191.90 | 189.55 |
Jan 26, 2023 | 192.30 | -1.90 | -0.98% | 194.20 | 195.45 | 192.30 |
Jan 25, 2023 | 190.45 | 1.65 | 0.87% | 188.80 | 191.00 | 187.15 |
Jan 24, 2023 | 189.45 | -2.55 | -1.33% | 192.00 | 192.75 | 188.80 |
Jan 23, 2023 | 192.55 | 3.30 | 1.74% | 189.25 | 193.05 | 188.45 |
Jan 20, 2023 | 186.55 | -1.80 | -0.96% | 188.35 | 191.20 | 186.50 |
Jan 19, 2023 | 189.35 | -1.50 | -0.79% | 190.85 | 191.00 | 186.80 |
Jan 18, 2023 | 192.35 | -3.95 | -2.01% | 196.30 | 196.40 | 192.15 |
Jan 17, 2023 | 196.00 | -2.70 | -1.36% | 198.70 | 198.75 | 195.40 |
Jan 16, 2023 | 199.20 | 1.15 | 0.58% | 198.05 | 200.00 | 197.85 |
Jan 13, 2023 | 197.65 | 2.45 | 1.26% | 195.20 | 197.75 | 193.15 |
Jan 12, 2023 | 196.75 | -3.15 | -1.58% | 199.90 | 200.30 | 192.85 |
Jan 11, 2023 | 200.70 | 6.95 | 3.59% | 193.75 | 202.20 | 193.55 |
Jan 10, 2023 | 192.00 | 2.40 | 1.27% | 189.60 | 192.60 | 189.00 |
Jan 9, 2023 | 193.55 | 5.00 | 2.65% | 188.55 | 193.60 | 187.40 |
Merck KGaA - EUR Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- 年度
- 每季度
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
总收入 | 15024 | 14517 | 14836 | 16152 | 17534 | 19687 |
收入 | 15024 | 14517 | 14836 | 16152 | 17534 | 19687 |
收入成本,共计 | 5201 | 5071 | 5342 | 5951 | 6782 | 7325 |
毛利 | 9823 | 9446 | 9494 | 10201 | 10752 | 12362 |
总营业费用 | 12543 | 12094 | 13109 | 14032 | 14549 | 15508 |
销售/一般/行政费用,总计 | 4409 | 4234 | 4256 | 4686 | 4600 | 4855 |
研究与开发 | 1972 | 2102 | 2220 | 2239 | 2262 | 2400 |
Depreciation / Amortization | 1036 | 1020 | 979 | 923 | 636 | 589 |
利息费用(收入) - 净运营 | 57 | 3 | 62 | 1 | ||
异常费用(收入) | -46 | -26 | 339 | 389 | 85 | 184 |
Other Operating Expenses, Total | -86 | -310 | -89 | -156 | 184 | 154 |
营业收入 | 2481 | 2423 | 1727 | 2120 | 2985 | 4179 |
利息收入(费用),非经营净值 | -274 | -243 | -209 | -338 | -350 | -255 |
其他,净值 | -53 | -51 | -57 | -47 | -5 | 0 |
税前净收入 | 2154 | 2129 | 1461 | 1735 | 2630 | 3924 |
税后净收入 | 1633 | 2557 | 1093 | 1295 | 1993 | 3065 |
少数股东权益 | -4 | -10 | -22 | -3 | -7 | -10 |
未计算非常项目前的净收益 | 1629 | 2547 | 1071 | 1292 | 1986 | 3055 |
非常规项目总计 | 0 | 57 | 2303 | 28 | 0 | |
净收入 | 1629 | 2604 | 3374 | 1320 | 1986 | 3055 |
普通股股东可获收益 (不含非经常性项目) | 1629 | 2548 | 1071 | 1292 | 1987 | 3055 |
普通股股东可获收益 (含非經常性項目) | 1629 | 2605 | 3374 | 1320 | 1987 | 3055 |
摊薄净收入 | 1629 | 2605 | 3374 | 1320 | 1987 | 3055 |
摊薄后加权平均股 | 434.778 | 434.778 | 434.794 | 434.211 | 434.792 | 434.566 |
扣除特别项目的每股摊薄盈利 | 3.74674 | 5.86046 | 2.46324 | 2.97552 | 4.57 | 7.03 |
Dividends per Share - Common Stock Primary Issue | 1.2 | 1.25 | 1.25 | 1.3 | 1.4 | 1.85 |
每股正常摊薄盈利 | 3.66653 | 5.91727 | 3.04653 | 3.6442 | 4.71815 | 7.36072 |
Total Adjustments to Net Income | 1 | 0 | 1 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
总收入 | 4631 | 4870 | 4973 | 5213 | 5198 |
收入 | 4631 | 4870 | 4973 | 5213 | 5198 |
收入成本,共计 | 1721 | 1813 | 1859 | 1959 | 1987 |
毛利 | 2910 | 3057 | 3114 | 3254 | 3211 |
总营业费用 | 3588 | 3821 | 3926 | 4174 | 4025 |
销售/一般/行政费用,总计 | 1280 | 1342 | 1376 | 1546 | 1374 |
研究与开发 | 574 | 585 | 660 | 590 | 586 |
异常费用(收入) | 6 | 0 | -1 | -6 | 5 |
Other Operating Expenses, Total | 7 | 81 | 32 | 85 | 73 |
营业收入 | 1043 | 1049 | 1047 | 1039 | 1173 |
利息收入(费用),非经营净值 | -60 | -95 | -54 | -47 | -34 |
其他,净值 | 1 | 1 | |||
税前净收入 | 984 | 955 | 993 | 992 | 1139 |
税后净收入 | 748 | 747 | 764 | 806 | 884 |
少数股东权益 | -1 | -2 | -3 | -4 | -3 |
未计算非常项目前的净收益 | 747 | 745 | 761 | 802 | 881 |
净收入 | 747 | 745 | 761 | 802 | 881 |
普通股股东可获收益 (不含非经常性项目) | 747 | 745 | 761 | 802 | 880 |
普通股股东可获收益 (含非經常性項目) | 747 | 745 | 761 | 802 | 880 |
摊薄净收入 | 747 | 745 | 761 | 802 | 880 |
摊薄后加权平均股 | 434.302 | 434.778 | 434.857 | 433.438 | 435.644 |
扣除特别项目的每股摊薄盈利 | 1.72 | 1.71352 | 1.75 | 1.85032 | 2.02 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 1.85 | 0 |
每股正常摊薄盈利 | 1.80927 | 1.90422 | 1.8827 | 1.80908 | 2.07345 |
Total Adjustments to Net Income | 0 | -1 |
- 年度
- 每季度
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
流动资产总额 | 7670 | 7455 | 9236 | 9003 | 9280 | 10982 |
现金和短期投资 | 981 | 623 | 2199 | 598 | 1234 | 1685 |
现金等价物 | 662 | 481 | 779 | 541 | 1109 | 1511 |
短期投资 | 319 | 142 | 1420 | 57 | 125 | 174 |
应收账款总额,净额 | 3607 | 3707 | 3738 | 4233 | 3910 | 4345 |
Accounts Receivable - Trade, Net | 2888 | 2923 | 3278 | 3644 | 3390 | 3853 |
Total Inventory | 2609 | 2632 | 2764 | 3342 | 3294 | 3900 |
Prepaid Expenses | 276 | 338 | 435 | 493 | 519 | 570 |
Other Current Assets, Total | 197 | 155 | 100 | 337 | 323 | 482 |
Total Assets | 38258 | 35621 | 36888 | 43811 | 41796 | 45362 |
Property/Plant/Equipment, Total - Net | 4231 | 4512 | 4811 | 6213 | 6421 | 7217 |
Property/Plant/Equipment, Total - Gross | 9404 | 9853 | 10551 | 12561 | 13228 | 14810 |
Accumulated Depreciation, Total | -5172 | -5340 | -5740 | -6348 | -6808 | -7593 |
Goodwill, Net | 15015 | 13582 | 13764 | 17141 | 15959 | 17004 |
Intangibles, Net | 9980 | 8317 | 7237 | 9175 | 7653 | 7612 |
Long Term Investments | 191 | 419 | 1 | 3 | ||
Note Receivable - Long Term | 15 | 41 | 614 | 746 | 830 | 922 |
Other Long Term Assets, Total | 1156 | 1295 | 1226 | 1533 | 1652 | 1622 |
Total Current Liabilities | 9089 | 8635 | 8517 | 11842 | 9231 | 10432 |
Accounts Payable | 2048 | 2195 | 1766 | 2054 | 1768 | 2380 |
Accrued Expenses | 603 | 778 | 799 | 791 | 975 | 1204 |
Notes Payable/Short Term Debt | 1855 | 1173 | 982 | 2224 | 515 | 1434 |
Current Port. of LT Debt/Capital Leases | 1908 | 1590 | 1217 | 2307 | 1780 | 1062 |
Other Current Liabilities, Total | 2675 | 2899 | 3753 | 4466 | 4193 | 4352 |
Total Liabilities | 24269 | 21618 | 19688 | 25945 | 24850 | 24024 |
Total Long Term Debt | 8706 | 7947 | 6608 | 8588 | 9745 | 8270 |
Long Term Debt | 8706 | 7947 | 6608 | 8130 | 9418 | 7928 |
Deferred Income Tax | 2724 | 1489 | 1288 | 1828 | 1441 | 1411 |
Minority Interest | 61 | 63 | 33 | 48 | 71 | 78 |
Other Liabilities, Total | 3689 | 3484 | 3242 | 3639 | 4362 | 3833 |
Total Equity | 13989 | 14003 | 17200 | 17866 | 16946 | 21338 |
Preferred Stock - Non Redeemable, Net | 397 | 397 | 397 | 397 | 397 | 397 |
Common Stock | 168 | 168 | 168 | 168 | 168 | 168 |
Additional Paid-In Capital | 3814 | 3814 | 3814 | 3814 | 3814 | 3814 |
Retained Earnings (Accumulated Deficit) | 8049 | 9902 | 12532 | 13236 | 14556 | 16673 |
Other Equity, Total | 1561 | -278 | 289 | 251 | -1989 | 286 |
Total Liabilities & Shareholders’ Equity | 38258 | 35621 | 36888 | 43811 | 41796 | 45362 |
Total Common Shares Outstanding | 434.778 | 434.778 | 434.778 | 434.778 | 434.778 | 434.778 |
Capital Lease Obligations | 458 | 327 | 342 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 10617 | 10182 | 10315 | 10982 | 11085 |
现金和短期投资 | 2298 | 1870 | 1665 | 2073 | 1445 |
现金等价物 | 2238 | 1825 | 1523 | 1899 | 1339 |
短期投资 | 60 | 45 | 142 | 174 | 106 |
应收账款总额,净额 | 4226 | 4124 | 4207 | 4345 | 4705 |
Accounts Receivable - Trade, Net | 3816 | 3771 | 3930 | 3853 | 4345 |
Total Inventory | 3462 | 3564 | 3760 | 3900 | 4143 |
Other Current Assets, Total | 631 | 624 | 683 | 664 | 792 |
Total Assets | 43891 | 43145 | 43836 | 45362 | 46235 |
Property/Plant/Equipment, Total - Net | 6552 | 6601 | 6761 | 7217 | 7303 |
Goodwill, Net | 16541 | 16347 | 16670 | 17004 | 17761 |
Intangibles, Net | 7765 | 7613 | 7628 | 7612 | 7549 |
Long Term Investments | 770 | 744 | 794 | 914 | 905 |
Note Receivable - Long Term | 38 | 39 | 39 | 35 | 35 |
Other Long Term Assets, Total | 1608 | 1619 | 1629 | 1598 | 1597 |
Total Current Liabilities | 10652 | 9820 | 9793 | 10432 | 10207 |
Accounts Payable | 1937 | 2107 | 2132 | 2380 | 2356 |
Accrued Expenses | 118 | 144 | 191 | 224 | 174 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 3347 | 3278 | 2770 | 2531 | 2345 |
Other Current Liabilities, Total | 5250 | 4291 | 4700 | 5297 | 5332 |
Total Liabilities | 24975 | 23852 | 23229 | 24024 | 23316 |
Total Long Term Debt | 9001 | 8721 | 8195 | 8270 | 8286 |
Long Term Debt | 9001 | 8721 | 8195 | 8270 | 8286 |
Deferred Income Tax | 1440 | 1401 | 1374 | 1411 | 1389 |
Minority Interest | 67 | 68 | 72 | 78 | 71 |
Other Liabilities, Total | 3815 | 3842 | 3795 | 3833 | 3363 |
Total Equity | 18916 | 19293 | 20607 | 21338 | 22919 |
Preferred Stock - Non Redeemable, Net | 397 | 397 | 397 | 397 | |
Common Stock | 168 | 168 | 168 | 168 | 565 |
Additional Paid-In Capital | 3814 | 3814 | 3814 | 3814 | 3814 |
Retained Earnings (Accumulated Deficit) | 15240 | 15799 | 16556 | 16673 | 18540 |
Other Equity, Total | -703 | -885 | -328 | 286 | |
Total Liabilities & Shareholders’ Equity | 43891 | 43145 | 43836 | 45362 | 46235 |
Total Common Shares Outstanding | 434.778 | 434.778 | 434.778 | 434.778 | 434.778 |
- 年度
- 每季度
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
净收入/起跑线 | 1633 | 2615 | 3396 | 1324 | 1994 | 3065 |
经营活动产生的现金 | 2510 | 2696 | 2219 | 2856 | 3477 | 4616 |
经营活动产生的现金 | 1934 | 1758 | 1812 | 1944 | 1938 | 1762 |
非现金物品 | -488 | -250 | -2523 | 149 | -59 | 62 |
营运资金的变化 | -569 | -1427 | -466 | -561 | -396 | -273 |
投资活动产生的现金 | -503 | -1147 | 2191 | -6153 | -1340 | -1578 |
资本支出 | -848 | -1311 | -1016 | -1021 | -1563 | -1421 |
其他投资现金流量项目,总计 | 345 | 164 | 3207 | -5132 | 223 | -157 |
融资活动产生的现金 | -1908 | -1870 | -2825 | 1902 | -1522 | -2504 |
融资现金流项目 | -464 | -469 | -607 | -527 | -519 | -576 |
Total Cash Dividends Paid | -136 | -155 | -162 | -162 | -168 | -181 |
债务的发行(退还),净额 | -1308 | -1246 | -2056 | 2591 | -835 | -1747 |
外汇效应 | 8 | -30 | -5 | 5 | -40 | 9 |
现金净变化 | 107 | -351 | 1580 | -1390 | 575 | 543 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 748 | 1495 | 2258 | 3065 | 884 |
Cash From Operating Activities | 1216 | 2104 | 3571 | 4616 | 840 |
Cash From Operating Activities | 424 | 843 | 1287 | 1762 | 430 |
Non-Cash Items | 6 | 25 | 46 | 62 | -24 |
Changes in Working Capital | 38 | -259 | -20 | -273 | -450 |
Cash From Investing Activities | -346 | -587 | -1226 | -1578 | -1089 |
Capital Expenditures | -362 | -638 | -1155 | -1421 | -498 |
Other Investing Cash Flow Items, Total | 16 | 51 | -71 | -157 | -591 |
Cash From Financing Activities | 6 | -1054 | -2184 | -2504 | -315 |
Financing Cash Flow Items | -55 | -575 | -575 | -576 | -100 |
Total Cash Dividends Paid | 0 | -181 | -181 | -181 | 0 |
Issuance (Retirement) of Debt, Net | 61 | -298 | -1428 | -1747 | -215 |
Foreign Exchange Effects | 7 | 6 | 7 | 9 | 4 |
Net Change in Cash | 883 | 469 | 168 | 543 | -560 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.8422 | 8842949 | 0 | 2022-09-27 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 4.84 | 6255325 | 3997581 | 2022-09-27 | LOW |
Fidelity International | Investment Advisor | 3.0193 | 3902150 | 2587266 | 2022-09-19 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 2.9271 | 3783100 | -924069 | 2022-05-18 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 2.8682 | 3706864 | -407104 | 2022-12-14 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.8079 | 3629024 | 3672 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.3464 | 3032598 | 488031 | 2022-12-31 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 1.9124 | 2471640 | 83238 | 2022-12-31 | LOW |
FMR Investment Management (U.K.) Limited | Investment Advisor | 1.3005 | 1680776 | -5936 | 2022-12-31 | LOW |
Deka Investment GmbH | Investment Advisor/Hedge Fund | 1.1334 | 1464775 | -25955 | 2022-12-31 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 1.1038 | 1426513 | 15622 | 2022-12-31 | LOW |
Allianz Global Investors GmbH | Investment Advisor | 1.0531 | 1361000 | -28942 | 2022-11-30 | LOW |
Union Investment Privatfonds GmbH | Investment Advisor | 0.9614 | 1242564 | 560959 | 2022-09-30 | LOW |
Eleva Capital SAS | Investment Advisor | 0.8919 | 1152665 | 25800 | 2022-10-31 | HIGH |
MFS International Singapore Pte. Ltd | Investment Advisor | 0.8661 | 1119411 | -22611 | 2022-12-31 | LOW |
BNP Paribas Asset Management France SAS | Investment Advisor/Hedge Fund | 0.8255 | 1066840 | -1655 | 2022-12-31 | LOW |
Lazard Asset Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7985 | 1031971 | -21628 | 2022-12-31 | LOW |
Walter Scott & Partners Ltd. | Investment Advisor/Hedge Fund | 0.7721 | 997924 | -204 | 2022-12-31 | LOW |
J O Hambro Capital Management Limited | Investment Advisor/Hedge Fund | 0.7686 | 993311 | -119431 | 2022-09-30 | MED |
California Public Employees' Retirement System | Pension Fund | 0.7543 | 974843 | -146711 | 2021-06-30 | LOW |
为什么选择 Capital.com?让我们的数字来说话。
Capital.com Group交易計算器
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
貿易佣金
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
杠杆
20:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
開倉
平倉
做空 做多
Merck - EUR Company profile
关于 Merck KGaA - EUR
默克公司是一家总部设在德国的科学和技术公司。 公司在三个业务领域运营。 医疗保健、生命科学和电子。 医疗保健业务在美国和加拿大以EMD雪兰诺公司的名义运营,专注于过敏、生育、肿瘤和神经退行性疾病等治疗领域,开发药物、诊断物质和医疗设备。 生命科学业务包括MilliporeSigma的活动,它提供促进生物技术和制药研究的解决方案。 产品范围包括实验室用水系统、基因编辑工具、细胞系和端到端药物制造系统等。 电子业务使数字生活成为可能,并为各种应用提供特种化学品,包括用于电子显示器的液晶、集成电路的材料、用于涂料和彩色化妆品的效果颜料,以及用于能源解决方案的功能材料。
Industry: | Proprietary & Advanced Pharmaceuticals |
Frankfurter Str. 250
DARMSTADT
HESSEN 64293
DE
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球485,000万多名交易者的一份子,选择利用Capital.com进行交易吧。